+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dry Eye Syndrome Market by Product Type, Treatment Type, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Dry Eye Syndrome Market by Product Type, Treatment Type, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Dry Eye Syndrome Market by Product Type, Treatment Type, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896652
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dry Eye Syndrome Market is projected to reach USD 5.37 Billion in 2026. It is expected to continue growing at a CAGR of 7.52%, reaching USD 8.35 Billion by 2032.

Dry Eye Syndrome, also known as dry eye disease, is a chronic, multifactorial ocular surface disorder associated with tear film instability, inflammation, hyperosmolarity, and neurosensory abnormalities, as defined by TFOS DEWS II. The condition affects visual comfort, reading speed, screen tolerance, contact lens wear, post-surgical recovery, workplace productivity, and overall quality of life.

The dry eye syndrome landscape is expanding as aging populations, prolonged digital device use, cataract and refractive surgery volumes, autoimmune diseases, diabetes, contact lens adoption, air pollution, and low-humidity environments increase the burden of evaporative dry eye and aqueous-deficient dry eye. Growth is strongest where diagnosis is shifting from symptom-based care toward objective testing, targeted prescription therapies, lipid-layer support, and device-based management of meibomian gland dysfunction.

Transformative Shifts in the Dry Eye Landscape

The dry eye landscape is moving beyond artificial tears toward mechanism-based treatment pathways. Clinicians increasingly differentiate aqueous-deficient dry eye from evaporative dry eye, particularly meibomian gland dysfunction, using tear osmolarity, inflammatory markers, ocular surface staining, tear breakup time, meibography, and patient-reported outcome tools.

Commercial innovation is concentrated in preservative-free lubricants, anti-inflammatory therapies such as cyclosporine and lifitegrast, neurostimulation approaches, tear conservation, thermal pulsation, intense pulsed light, and lipid-targeted treatments. This shift is raising the value of evidence-backed products that demonstrate durable symptom relief, objective sign improvement, safety in chronic use, and compatibility with digital health-enabled eye care.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative enabler across dry eye screening, diagnosis, clinical workflow, and patient monitoring. AI-supported image analysis can help quantify meibomian gland dropout, lid margin changes, blink patterns, ocular redness, and tear film behavior, while electronic health record analytics can identify high-risk patients based on age, medication exposure, autoimmune disease, diabetes, ocular surgery history, and screen-intensive occupations.

For manufacturers and providers, AI can improve trial design, segment patients by phenotype, support adherence programs, and personalize treatment escalation. Adoption will depend on clinically validated algorithms, transparent performance metrics, bias testing across diverse populations, cybersecurity controls, and alignment with medical device and software-as-a-medical-device regulations.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific represents a high-volume growth arena due to large aging populations, urbanization, high digital device exposure, contact lens use, pollution exposure, and rising access to ophthalmology services in China, Japan, India, South Korea, Australia, and ASEAN markets. North America remains a leading value market, supported by specialist eye care networks, optometry-led diagnosis, prescription therapy adoption, established regulatory pathways, and high patient awareness of chronic ocular surface disease.

Europe benefits from structured clinical practice, strong optometry and ophthalmology access, and regulatory emphasis on product safety, although pricing and reimbursement vary across countries. Latin America is expanding through private eye care, retail pharmacy access, and improving awareness in Brazil and Mexico. The Middle East faces elevated dry eye risk from arid climates, air conditioning, dust exposure, and screen use, while Africa remains underdiagnosed, with growth tied to access, affordability, professional training, and distribution expansion.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are gaining momentum as urban eye care infrastructure, medical tourism, rising contact lens use, and digital lifestyles increase diagnosis and demand for lubricants, diagnostics, and office-based procedures. GCC countries show strong need for dry eye management because hot, dry climates, indoor air conditioning, high screen exposure, and premium healthcare investment create a favorable environment for advanced diagnostics and prescription products.

The European Union provides a harmonized regulatory foundation for medical products, although market access and reimbursement decisions remain country-specific. BRICS countries offer scale, local manufacturing opportunities, and expanding middle-class demand, while the G7 continues to lead in clinical research, premium therapeutics, diagnostic adoption, and evidence-based reimbursement. NATO markets are relevant for operational vision readiness, defense healthcare systems, and resilient medical supply chains across allied countries.

Key Country Insights Across Major Dry Eye Markets

The United States leads in prescription dry eye innovation, clinical trials, device adoption, and consumer awareness, while Canada shows steady demand through optometry-led care and access to preservative-free products. Mexico and Brazil are important Latin American markets where private ophthalmology, retail pharmacy channels, urbanization, and rising chronic disease prevalence support growth. In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from established eye care systems, aging demographics, and structured clinical pathways, while Russia presents demand shaped by local access, pricing, regulatory requirements, and supply conditions.

China and India offer major long-term volume potential because of population scale, digital lifestyles, pollution exposure, diabetes prevalence, and expanding specialist care. Japan and South Korea are sophisticated markets with high screen use, aging demographics, contact lens penetration, and strong ophthalmology adoption. Australia shows demand linked to aging, outdoor exposure, allergy burden, dry climate zones, and advanced optometry networks.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated portfolios that address both evaporative and aqueous-deficient dry eye, including preservative-free formulations, anti-inflammatory drugs, lipid-layer products, and device-enabled therapies for meibomian gland dysfunction. Evidence generation should include real-world outcomes, patient-reported improvement, objective sign changes, safety in chronic use, and comparative value versus standard care.

Organizations can accelerate growth by investing in clinician education, AI-enabled diagnostics, omnichannel patient engagement, and region-specific access strategies. Partnerships with ophthalmologists, optometrists, pharmacies, digital health platforms, and payers can improve diagnosis, adherence, and treatment continuity while strengthening credibility in a crowded dry eye market.

Research Methodology

This executive summary is built on validated secondary research and market intelligence synthesis, including clinical definitions from TFOS DEWS II, peer-reviewed dry eye epidemiology, regulatory frameworks, product approvals, treatment guidelines, healthcare infrastructure indicators, and regional access patterns. Insights were cross-checked to avoid unsupported claims and to reflect current clinical and commercial realities.

The methodology combines disease-burden assessment, segmentation by treatment modality and care pathway, regional demand mapping, technology trend analysis, and competitive landscape review. Qualitative interpretation was used only where supported by documented clinical practice, regulatory evidence, or observable market behavior, while avoiding market sizing, market share, and forecasting assumptions.

Conclusion

Dry Eye Syndrome is evolving from an often underrecognized discomfort condition into a clinically managed chronic ocular surface disease with strong demand for targeted, measurable, and long-term solutions. Growth is supported by aging, digitalization, environmental stressors, ocular procedures, chronic inflammatory conditions, and better diagnostic tools.

The strongest opportunities will favor organizations that combine science-backed therapies, objective diagnostics, AI-enabled personalization, clinician education, and locally relevant access models. As care becomes more phenotype-driven, the dry eye syndrome landscape is positioned for sustained innovation across pharmaceuticals, devices, diagnostics, and digital eye health.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Dry Eye Syndrome Market, by Product Type
7.1. Devices
7.2. Eye Drops
7.3. Eye Gels
7.4. Eye Ointments
7.5. Punctal Plugs
8. Dry Eye Syndrome Market, by Treatment Type
8.1. Artificial Tears
8.2. Medical Devices
8.3. Nutraceuticals
8.4. Prescription Drug Therapy
8.4.1. Corticosteroids
8.4.2. Cyclosporine
8.4.3. Lifitegrast
9. Dry Eye Syndrome Market, by End User
9.1. Clinics
9.2. Home Care
9.3. Hospitals
10. Dry Eye Syndrome Market, by Distribution Channel
10.1. Hospital Pharmacy
10.2. Online Pharmacy
10.3. Retail Pharmacy
11. Asia-Pacific Dry Eye Syndrome Market
12. North America Dry Eye Syndrome Market
13. Latin America Dry Eye Syndrome Market
14. Europe Dry Eye Syndrome Market
15. Middle East Dry Eye Syndrome Market
16. Africa Dry Eye Syndrome Market
17. ASEAN Dry Eye Syndrome Market
18. GCC Dry Eye Syndrome Market
19. European Union Dry Eye Syndrome Market
20. BRICS Dry Eye Syndrome Market
21. G7 Dry Eye Syndrome Market
22. NATO Dry Eye Syndrome Market
23. United States Dry Eye Syndrome Market
24. Canada Dry Eye Syndrome Market
25. Mexico Dry Eye Syndrome Market
26. Brazil Dry Eye Syndrome Market
27. United Kingdom Dry Eye Syndrome Market
28. Germany Dry Eye Syndrome Market
29. France Dry Eye Syndrome Market
30. Russia Dry Eye Syndrome Market
31. Italy Dry Eye Syndrome Market
32. Spain Dry Eye Syndrome Market
33. China Dry Eye Syndrome Market
34. India Dry Eye Syndrome Market
35. Japan Dry Eye Syndrome Market
36. Australia Dry Eye Syndrome Market
37. South Korea Dry Eye Syndrome Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. AbbVie Inc.
39.2. AFT Pharmaceuticals Ltd.
39.3. Akorn Operating Company LLC
39.4. Alcon Inc.
39.5. Bausch + Lomb Corporation
39.6. Johnson & Johnson Services, Inc.
39.7. Kala Pharmaceuticals, Inc.
39.8. Mitotech S.A.
39.9. Novaliq GmbH
39.10. Novartis AG
39.11. OASIS Medical, Inc.
39.12. Otsuka Pharmaceutical Co., Ltd.
39.13. Rohto Pharmaceutical Co., Ltd.
39.14. Santen Pharmaceutical Co., Ltd.
39.15. Senju Pharmaceutical Co., Ltd.
39.16. Similasan Corporation
39.17. Sun Pharmaceutical Industries Ltd.
39.18. Thea Pharmaceuticals Ltd.
39.19. United Laboratories Co., Ltd.
39.20. Ursapharm Arzneimittel GmbH
39.21. Zhejiang Jianfeng Group Co., Ltd.
List of Figures
FIGURE 1. GLOBAL DRY EYE SYNDROME MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DRY EYE SYNDROME MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DRY EYE SYNDROME MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DRY EYE SYNDROME MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. ASEAN DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. ASEAN DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. GCC DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. GCC DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. G7 DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. G7 DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. NATO DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. NATO DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. UNITED STATES DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. CANADA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. MEXICO DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. BRAZIL DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. GERMANY DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. FRANCE DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. RUSSIA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. ITALY DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. SPAIN DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CHINA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. INDIA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. JAPAN DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DRY EYE SYNDROME MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL EYE DROPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EYE DROPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EYE DROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EYE GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EYE GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EYE GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EYE OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EYE OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EYE OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PUNCTAL PLUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PUNCTAL PLUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PUNCTAL PLUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PRESCRIPTION DRUG THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PRESCRIPTION DRUG THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PRESCRIPTION DRUG THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CYCLOSPORINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CYCLOSPORINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CYCLOSPORINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL LIFITEGRAST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL LIFITEGRAST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LIFITEGRAST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. EUROPE DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 88. EUROPE DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. EUROPE DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. AFRICA DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 98. AFRICA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 99. AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 100. AFRICA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. AFRICA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. ASEAN DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. ASEAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 104. ASEAN DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASEAN DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 106. ASEAN DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. ASEAN DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. GCC DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GCC DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. GCC DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 111. GCC DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 112. GCC DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. GCC DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. BRICS DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. BRICS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. BRICS DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 123. BRICS DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 124. BRICS DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. BRICS DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. G7 DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. G7 DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. G7 DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 129. G7 DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 130. G7 DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. G7 DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. NATO DRY EYE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. NATO DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. NATO DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 135. NATO DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 136. NATO DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. NATO DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. CANADA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 145. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. CANADA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 147. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 148. CANADA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. CANADA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. MEXICO DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 151. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. MEXICO DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 153. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 154. MEXICO DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. MEXICO DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. BRAZIL DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 157. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 159. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 160. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 163. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 165. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 166. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. GERMANY DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 169. GERMANY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. GERMANY DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 171. GERMANY DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 172. GERMANY DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. GERMANY DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174. FRANCE DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 175. FRANCE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. FRANCE DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 177. FRANCE DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 178. FRANCE DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. FRANCE DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. RUSSIA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 181. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 183. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 184. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. ITALY DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. ITALY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. ITALY DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 189. ITALY DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 190. ITALY DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. ITALY DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. SPAIN DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. SPAIN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. SPAIN DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 195. SPAIN DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 196. SPAIN DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. SPAIN DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. CHINA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. CHINA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 201. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 202. CHINA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. CHINA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. INDIA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 205. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. INDIA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 207. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 208. INDIA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. INDIA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. JAPAN DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 211. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. JAPAN DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 213. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 214. JAPAN DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. JAPAN DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 217. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 219. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 220. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 223. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 225. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUG THERAPY, 2018-2032 (USD MILLION)
TABLE 226. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Dry Eye Syndrome market report include:
  • AbbVie Inc.
  • AFT Pharmaceuticals Ltd.
  • Akorn Operating Company LLC
  • Alcon Inc.
  • Bausch + Lomb Corporation
  • Johnson & Johnson Services, Inc.
  • Kala Pharmaceuticals, Inc.
  • Mitotech S.A.
  • Novaliq GmbH
  • Novartis AG
  • OASIS Medical, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Rohto Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Senju Pharmaceutical Co., Ltd.
  • Similasan Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Thea Pharmaceuticals Ltd.
  • United Laboratories Co., Ltd.
  • Ursapharm Arzneimittel GmbH
  • Zhejiang Jianfeng Group Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.35 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Dry Eye Syndrome Market Size, Share, Trends, and Forecast by Disease Type, Drug Type, Product, Distribution Channel, and Region, 2026-2034 - Product Image

Dry Eye Syndrome Market Size, Share, Trends, and Forecast by Disease Type, Drug Type, Product, Distribution Channel, and Region, 2026-2034

  • Report
  • 144 Pages
  • Global
From
Dry Eye Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Dry Eye Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 185 Pages
  • Global
From
Dry Eye Syndrome Market Report 2026 - Product Image

Dry Eye Syndrome Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Dry Eye Treatment Devices - Global Strategic Business Report - Product Image

Dry Eye Treatment Devices - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
OTC Dry Eye Drops - Global Strategic Business Report - Product Image

OTC Dry Eye Drops - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From

About the Dry Eye Drug Market

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators. Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.